Bird Flu > Bird Flu News > Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay

Aethlon Medical files provisional patent on behalf of ESI for exosome detection assay
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has filed a provisional patent on behalf of its wholly owned subsidiary Exosome Sciences, Inc. (ESI), relating to the development of an assay that will allow researchers to detect exosomes in blood and other fluids.